Guidelines from the Endocrine Society report that postmenopausal women with hypoactive sexual desire disorder may benefit from up to 6 months of testosterone replacement therapy but recommend against its use in otherwise healthy women.
Low testosterone is a common condition among men with diabetes—diabetic men are approximately twice as likely as others to develop low testosterone and hypogonadism. Because its symptoms mimic other conditions, patients often fail to report concerns and clinicians may fail to diagnose “Low T.”
New research suggested that men with the sort of wider faces that indicate higher testosterone levels show greater dominance and fare better than narrow-faced men in negotiations.
Do women prefer the sort of masculine faces that indicate high testosterone levels? New research suggests that the answer may depend upon where you live, but if you live in an advanced market economy, the answer is probably “yes.”
A recommendation by two FDA advisory panels to narrow the official approval for testosterone replacement therapy has won generally favorable reviews from medical organizations, although questions remain about its ultimate impact.
Do longer periods of androgen-deprivation therapy significantly improve prostate cancer survival rates or needlessly impair quality of life for recovering patients?